LEVOTHYROXINE SODIUM
LEVOTHYROXINE SODIUM
Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 215259 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2023-01-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 215259 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2023-01-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.